Literature DB >> 15079760

Are polymyalgia rheumatica and giant cell arteritis the same disease?

Fabrizio Cantini1, Laura Niccoli, Lara Storri, Carlotta Nannini, Ignazio Olivieri, Angela Padula, Luigi Boiardi, Carlo Salvarani.   

Abstract

OBJECTIVE: To summarize the evidence about the relationship between polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
METHODS: Review of relevant articles from the English-language literature.
RESULTS: Epidemiologic studies suggest that PMR and GCA are closely related conditions affecting people over 50 years and frequently occurring in the same patient. PMR symptoms have been observed in 40 to 60 percent of GCA clinical series. Also, temporal artery biopsy may yield positive results for GCA in patients with isolated PMR. Conflicting HLA-DRB1 genotype results have been reported, and recent studies have shown that PMR and GCA have different expression of RANTES, TNFalpha microsatellite, and IL-6 promoter genetic polymorphisms. Search for a possible common infectious agent have yielded disappointing results. Although parvovirus B19 DNA is present in the artery wall of patients with GCA, this virus may be only an innocent bystander. Cytokine studies on a limited number of temporal artery biopsy specimens have shown that interferon-gamma is produced in GCA and not in PMR, suggesting that this cytokine may be crucial to the development of overt vasculitis.
CONCLUSIONS: PMR and GCA frequently occur together but no definitive conclusions can be drawn about the nature of this association.

Entities:  

Mesh:

Year:  2004        PMID: 15079760     DOI: 10.1016/j.semarthrit.2003.09.008

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  18 in total

1.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.

Authors:  G A Hooisma; H Balink; P M Houtman; R H J A Slart; K D F Lensen
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

Review 2.  Giant cell arteritis.

Authors:  Todd J Schwedt; David W Dodick; Richard J Caselli
Journal:  Curr Pain Headache Rep       Date:  2006-12

Review 3.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Association between giant cell arteritis and thyroid dysfunction in a "real life" population.

Authors:  Yarden Yavne; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Endocrine       Date:  2017-06-16       Impact factor: 3.633

Review 5.  Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Authors:  Thomas Nothnagl; Burkhard F Leeb
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Association of ferritin antibodies with Takayasu arteritis.

Authors:  K Große; T Witte; F Moosig; B F Hoyer; C Lansche; R E Schmidt; N T Baerlecken
Journal:  Clin Rheumatol       Date:  2014-09-02       Impact factor: 2.980

Review 7.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

8.  Large-vessel giant cell arteritis: a cohort study.

Authors:  Francesco Muratore; Tanaz A Kermani; Cynthia S Crowson; Abigail B Green; Carlo Salvarani; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-09-05       Impact factor: 7.580

9.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

10.  Anterior uveitis as an initial manifestation of polymyalgia rheumatica.

Authors:  Hiromasa Tsuda; Kozue Tanaka; Shuji Kishida
Journal:  Case Rep Med       Date:  2011-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.